{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T14:11:10Z","timestamp":1774793470775,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":2618,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1038\/jid.2008.221","type":"journal-article","created":{"date-parts":[[2008,9,12]],"date-time":"2008-09-12T07:41:29Z","timestamp":1221205289000},"page":"2353-2354","source":"Crossref","is-referenced-by-count":17,"title":["Acne Vaccines: Therapeutic Option for the Treatment of Acne Vulgaris?"],"prefix":"10.1016","volume":"128","author":[{"given":"Jenny","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/jid.2008.221_bb0010","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2133.1997.tb03660.x","article-title":"IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris","volume":"136","author":"Ashbee","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2008.221_bb0015","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2133.1987.tb04899.x","article-title":"Antibodies to P. acnes and P. acnes exocellular enzymes in the normal population at various ages and in patients with acne vulgaris","volume":"116","author":"Ingham","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1038\/jid.2008.221_bb0020","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.4049\/jimmunol.169.3.1535","article-title":"Activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses","volume":"169","author":"Kim","year":"2002","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.221_bb0025","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000017868","article-title":"Propionibacterium acnes colonization in acne and non-acne","volume":"196","author":"Leyden","year":"1988","journal-title":"Dematology"},{"key":"10.1038\/jid.2008.221_bb0030","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.4049\/jimmunol.174.5.2467","article-title":"Cutting edge: all-trans retinoic acid down-regulates TLR2 expression and function","volume":"174","author":"Liu","year":"2005","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.221_bb0035","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.4049\/jimmunol.180.7.4919","article-title":"CD 209+ macrophages mediate host defense against Propionibacterium acnes","volume":"190","author":"Liu","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/jid.2008.221_bb0040","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.0022-202X.2005.23705.x","article-title":"Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through Toll-like receptors","volume":"124","author":"Nagy","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.221_bb0045","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.micinf.2006.04.001","article-title":"Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines\/chemokines in human sebocytes","volume":"8","author":"Nagy","year":"2006","journal-title":"Microbes Infect"},{"key":"10.1038\/jid.2008.221_bb0050","doi-asserted-by":"crossref","first-page":"e1551","DOI":"10.1371\/journal.pone.0001551","article-title":"Vaccination targeting a surface sialidase of P.acnes: implication for new treatment of acne vulgaris","volume":"3","author":"Nakatsuji","year":"2008","journal-title":"PloS ONE"},{"key":"10.1038\/jid.2008.221_bb0055","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/jid.2008.117","article-title":"Antibodies elicited by inactivated P. acnes\u2013based vaccines exert protective immunity and attenuate the IL-8 production in human sebocytes: relevance to therapy for acne vulgaris","volume":"128","author":"Nakatsuji","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1038\/jid.2008.221_bb0060","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/1523-1747.ep12273462","article-title":"Antibody titers to Propionibacterium acnes cell wall carbohydrate in nodulocystic acne patients","volume":"84","author":"Webster","year":"1985","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15336411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15336411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,13]],"date-time":"2019-05-13T23:36:20Z","timestamp":1557790580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15336411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0022202X15336411"],"URL":"https:\/\/doi.org\/10.1038\/jid.2008.221","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}